2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AJOG.2007.07.047PMID 17904957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.

  2009influential reference
• Quality management in gynecologic cytology using interlaboratory comparison.

  2009cited by this paper
• 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests

  2008cited by this paper
• Effective cervical neoplasia detection with a novel optical detection system: a randomized trial.

  2007cited by this paper
• Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

  2007cited by this paper
• Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results.

  2007cited by this paper
• Prevalence of HPV infection among females in the United States.

  2007cited by this paper
• 2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests

  2007cited by this paper
• Regression of Low-Grade Squamous Intra-epithelial Lesions in Young Women

  2006cited by this paper
• Human Papillomavirus DNA Testing in Routine Clinical Practice for Prediction of Underlying Cervical Intraepithelial Neoplasia 2/3+ at Initial Evaluation and in Follow-up of Women with Atypical Glandular Cell Papanicolaou Tests

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening

  2006cited by this paper
• Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

  2006cited by this paper
• Chapter 5: Updating the natural history of HPV and anogenital cancer.

  2006cited by this paper
• The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period.

  2006cited by this paper
• Rate of Pathology From Atypical Glandular Cell Pap Tests Classified by the Bethesda 2001 Nomenclature

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,

  2006cited by this paper
• Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.

  2006cited by this paper
• New dimensions in cervical cancer screening

  2006cited by this paper
• Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes

  2006cited by this paper
• Chapter 10: New dimensions in cervical cancer screening.

  2006cited by this paper
• Effect of HIV infection on atypical squamous cells of undetermined significance.

  2006cited by this paper
• Human papillomavirus testing using hybrid capture II with surepath collection

  2006cited by this paper
• Endometrial Cells in Cervical Cytology: Review of Cytological Features and Clinical Assessment

  2006influential reference
• HPV DNA Testing for Cervical Cancer Screening

  2006cited by this paper
• Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.

  2006cited by this paper
• Cytologic–histologic correlation of screening and diagnostic Papanicolaou tests

  2006cited by this paper
• Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

  2006cited by this paper
• Dysplasia Associated With Atypical Glandular Cells on Cervical Cytology

  2005cited by this paper
• Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2–3 in young versus elderly women

  2005cited by this paper
• The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

  2005influential reference
• HPV triage of women with atypical squamous cells of undetermined significance: a 3‐year experience in an Italian organized programme

  2005cited by this paper
• Carcinogenicity of human papillomaviruses.

  2005cited by this paper
• ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus.

  2005cited by this paper
• A Prospective Evaluation of "See and Treat" in Women with HSIL Pap Smear Results: Is This an Appropriate Strategy?

  2005cited by this paper
• The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women

  2005cited by this paper
• Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001.

  2005cited by this paper
• Atypical Squamous Cells of Undetermined Significance: Human Papillomavirus Testing in Adolescents

  2005influential reference
• Virologic versus cytologic triage of women with equivocal Pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

  2004cited by this paper
• Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

  2004cited by this paper
• ASC‐US and HPV testing in women aged 40 years and over

  2004cited by this paper
• Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

  2004cited by this paper
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening

  2004influential reference
• Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.

  2004cited by this paper
• High-Risk Human Papillomavirus and Cervical Intraepithelial Neoplasia at Time of Atypical Squamous Cells of Undetermined Significance Cytologic Results in a Population with Human Immunodeficiency Virus

  2004cited by this paper
• Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More

  2004cited by this paper
• Regression of low-grade squamous intra-epithelial lesions in young women.

  2004cited by this paper
• Diagnoses and outcomes in cervical cancer screening: a population-based study.

  2004cited by this paper
• HPV Testing for Triage of HIV-Infected Women with Papanicolaou Smears Read as Atypical Squamous Cells of Uncertain Significance

  2004cited by this paper
• Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing.

  2004cited by this paper
• Interlaboratory reproducibility of atypical squamous cells of undetermined significance report: a national survey

  2003cited by this paper
• Management of women who test positive for high-risk types of human papillomavirus: the HART study.

  2003cited by this paper
• Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.

  2003cited by this paper
• Adding a test for human papillomavirus DNA to cervical-cancer screening.

  2003cited by this paper
• Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

  2003cited by this paper
• Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.

  2003cited by this paper
• A “See and Treat” Management for High-Grade Squamous Intraepithelial Lesion Pap Smears

  2003cited by this paper
• Evaluation of adjunctive HPV testing by Hybrid Capture II® in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy

  2003cited by this paper
• Triage of Atypical Squamous Cells of Undetermined Significance With Hybrid Capture II: Colposcopy and Histologic Human Papillomavirus Correlation

  2003cited by this paper
• A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.

  2003cited by this paper
• A retrospective review on atypical glandular cells of undetermined significance (AGUS) using the Bethesda 2001 classification.

  2003cited by this paper
• 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities.

  2002cited by this paper
• American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

  2002cited by this paper
• Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy.

  2002cited by this paper
• Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities

  2002cited by this paper
• Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.

  2002cited by this paper
• The 2001 Bethesda System: terminology for reporting results of cervical cytology.

  2002cited by this paper
• Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

  2002cited by this paper
• Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations.

  2002cited by this paper
• Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.

  2001cited by this paper
• Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

  2001cited by this paper
• Guide to development of practice guidelines.

  2001cited by this paper
• Biopsy correlates of abnormal cervical cytology classified using the Bethesda system.

  2001cited by this paper
• Smears diagnosed as ASCUS: Interobserver variation and follow‐up

  2001cited by this paper
• Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.

  2001cited by this paper
• Management of the Minimally Abnormal Papanicolaou Smear in Pregnancy

  2001cited by this paper
• Evolution of Cervical Abnormalities Among Women With HIV‐1: Evidence From Surveillance Cytology in the Women's Interagency HIV Study

  2001cited by this paper
• Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.

  2001influential reference
• Frequency of Cervical Smear Abnormalities Within 3 Years of Normal Cytology

  2000cited by this paper
• Human Papillomavirus Testing in Women With Mild Cytologic Atypia

  2000cited by this paper
• Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories.

  2000cited by this paper
• See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis.

  1999cited by this paper
• Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.

  1999cited by this paper
• NATURAL HISTORY OF CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS: A META‐ANALYSIS

  1998cited by this paper
• Purpose of quality standards for infectious diseases. Infectious Diseases Society of America.

  1994cited by this paper
• Purpose of Quality Standards for Infectious Diseases

  1994cited by this paper

• Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review.

  2026cites this paper
• Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants

  2025cites this paper
• A Mixed-Methods Study Examining Guideline-Concordant Colposcopy Practices Among a National Cohort of US Colposcopists

  2025cites this paper
• The DNA Methylation Marker ZNF671 Has Prognostic Value for Progressing Cervical Intraepithelial Neoplasia

  2025cites this paper
• Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screening

  2025cites this paper
• Cytoplasm and nuclei as a basis for Bethesda cell cluster classification in cervical smears

  2025cites this paper
• The role of photodynamic therapy in treating LSIL in women with high-risk HPV: a literature review

  2025cites this paper
• POSITIVE CONE MARGINS - A DISADVANTAGE OF THE LARGE LOOP EXCISION OF TRANSFORMATION ZONE TECHNIQUE?

  2024cites this paper
• Evaluation of The Sensitivity and Specificity of Colposcopy in The Early Detection of Dysplasia

  2024cites this paper
• Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study

  2024cites this paper
• PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy

  2024cites this paper
• Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.

  2024cites this paper
• Barriers and Facilitators to Cervical Cancer vaccination Among Young Females in Chennai: A Cross-Sectional KAP Study

  2024cites this paper
• Genotype profile of HPV in ASC‐H cytology and histologic follow‐up—prevalence, distribution, and risk: A retrospective study of 1414 cases

  2024cites this paper
• Pregnancy-Related Precancerous Cervical Lesions: Pathogenesis, Diagnosis, Evolution, and Impact upon Gestation and Fertility

  2024cites this paper
• Methylation of SOX1 and PAX1 Are Risk Factors and Potential Biomarkers for Cervical Lesions

  2024cites this paper
• The Fate of Cervical Dysplastic Lesions during Pregnancy and the Impact of the Delivery Mode: A Review

  2023cites this paper
• Precancerous Cervical Lesion and Associated Factors Among Women of Reproductive Age Group at Adama Hospital and Medical College, Adama, Ethiopia

  2023cites this paper
• Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations

  2023cites this paper
• Timing of Colposcopy and Risk of Cervical Cancer

  2023cites this paper
• An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation

  2022cites this paper
• Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

  2022cites this paper
• The effect of other high-risk HPV types on cervical intraepithelial neoplasia and cancer

  2022cites this paper
• Health issues in the ageing woman

  2022cites this paper
• Regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) managed expectantly.

  2022cites this paper
• A Deep Learning Model for Cervical Cancer Screening on Liquid-Based Cytology Specimens in Whole Slide Images

  2022cites this paper
• HPV Pozitif Kadınlarda ASC-US ve LSIL Sitolojilerinin Klinik Veri ve Kolposkopi Sonuçlarının Karşılaştırılması

  2022cites this paper
• Epigenetic biomarker and drug development in gynecological cancers

  2022cites this paper
• Preventing Uterine Cervix Cancer: The Clinical Meaning of Atypical Glandular Cells

  2022cites this paper
• Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study

  2022cites this paper
• Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening?

  2021cites this paper
• Risk of High-Grade Cervical Lesions in Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Comparison between HIV-Infected and HIV-Negative Women

  2021cites this paper
• Cost-effectiveness Analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

  2021cites this paper
• Prevalence and Associated Factors of Precancerous Cervical Lesions among Women in Ethiopia: A Systematic Review and Meta-Analysis

  2021cites this paper
• Persistence and clearance patterns of cervical high risk human papillomavirus (Hr-HPV) infections in women with negative cytology results in Harare, Zimbabwe

  2021cites this paper
• A retrospective study comparing the efficiency of recurrent LSIL cytology to high-grade cytology as predictors of high-grade cervical intraepithelial neoplasia or worse (CIN2+)

  2021cites this paper
• Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China

  2021cites this paper
• Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016–2020

  2021cites this paper
• Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations

  2021cites this paper
• Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence.

  2021cites this paper
• Jak HPV wysokiego ryzyka indukuje optymalne środowisko dla własnej replikacji w różnicującym się nabłonku

  2021cites this paper
• Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade 2 or more severe lesions among a cohort of colposcoped women in Kaiser Permanente Southern California.

  2021cites this paper
• Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA

  2021cites this paper
• Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study

  2021cites this paper
• The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes

  2021cites this paper
• Screening tests for endometrial cancer in the general population

  2021cites this paper
• A bibliometric analysis of obstetrics and gynecology articles with highest relative citation ratios, 1980 to 2019.

  2020cites this paper
• Squamous intraepithelial lesions of the cervix: a modern view of etiology, pathogenesis, and diagnosis

  2020cites this paper
• 495 The effect of other high-risk HPV types on cervical intraepithelial neoplasia and cancer

  2020cites this paper
• Papanicolaou smear: A diagnostic aid in sexually transmitted infections

  2020cites this paper
• CMAR_A_254330 5265..5275

  2020cites this paper
• Genital Human Papillomavirus Infection

  2020cites this paper
• Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions

  2020cites this paper
• HPV co-testing as cervical screening test, Experience of Alweiya early detection cervical clinic: one-year Analysis

  2020cites this paper
• Cervical Intraepithelial Neoplasia

  2020cites this paper
• Knowledge of cervical cancer screening among women in Farin Tanki Area Argungu, Kebbi State, Nigeria

  2020cites this paper
• A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States

  2020cites this paper
• ABNORMAL FINDING OF PAP SMEAR AMONG WOMEN HOSPITAL VISITORS IN CITY OF MOSUL, IRAQ

  2020cites this paper
• Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection

  2020cites this paper
• Loop electrosurgical excision procedure (LEEP) plus top hat for HIV‐infected women with endocervical intraepithelial neoplasia in Kenya

  2020cites this paper
• Avaliação da prevalência de alterações citológicas de mulheres atendidas em diferentes redes do sistema de saúde do Brasil no período de 2011 a 2015

  2020cites this paper
• The Efficiency of Type-Specific High-Risk Human Papillomavirus Models in the Triage of Women with Atypical Squamous Cells of Undetermined Significance

  2020cites this paper
• Re-evaluation of Negative Cone Biopsy Results with Ki-67 and p16 Immunostaining following Positive Cervical Biopsy

  2020cites this paper
• Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high‐risk HPV: A retrospective review of 6000 cases in a large academic women's hospital

  2020cites this paper
• Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2)

  2020cites this paper
• Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

  2020cites this paper
• Primary HPV screening for cervical cancer.

  2020cites this paper
• 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

  2020cites this paper
• A Sensitive and Simplified Classifier of Cervical Lesions Based on a Methylation-Specific PCR Assay: A Chinese Cohort Study

  2020cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Evaluation of colposcopy results for patients who are HPV DNA positive in KETEM

  2019cites this paper
• Human Papillomavirus Infection

  2019cites this paper
• Correlation between Uterine Cervical Lesion and HPV in Busan Region

  2019cites this paper
• A comparison of liquid-based and conventional cytology using data for cervical cancer screening from the Japan Cancer Society.

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Human Papillomavirus Infection

  2019cites this paper
• Analysis of cytological false negatives of carcinoma of cervix

  2019cites this paper
• Top‐cited articles in the Journal: a bibliometric analysis

  2019cites this paper
• Cervical Cancer Screening ( PDQ ® ) – Health Professional Version

  2019cites this paper
• Legal Aspects of Office-Based Women’s Health Procedures

  2019cites this paper
• Human Papillomavirus Infection

  2019cites this paper
• Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Biomarkers for the Early Detection of Cervical Cancer

  2019cites this paper
• Human Papillomavirus Infection

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Prevalence of Unsatisfactory Pap Smear and Associated Clinical History and Diagnosis in a Tertiary Teaching Hospital in Ghana

  2019cites this paper
• Morphometric analysis of atypical glandular cells correctly classifies normal, reactive, and atypical cells in cervical smears

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper
• Follow‐up with histopathology and HPV testing on LSIL cytology in China’s largest academic woman’s hospital

  2019cites this paper
• Human Papillomavirus Infection

  2019cites this paper
• Human Papillomavirus Infection-Core Concepts

  2019cites this paper